Skip to main content
. 2021 Oct 29;12:732478. doi: 10.3389/fphar.2021.732478

FIGURE 3.

FIGURE 3

PCA and PLS-DA. (A) PCA score of control (n = 6), ANIT (n = 6), and MBT1805 30 mg/kg treatment (treat, n = 5). (B) Score plots of PLS-DA. (C) PLS-DA model maturation test with 100 (Q2 intercept =0.048). (D) VIP values with threshold, VIP ≥ 2.